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Having read with great interest the article by Goto et al1 and in order to clarify further 
some of the results presented in this article, especially with regard to the action of 
atypical antipsychotic drugs on glutamate and the glutamine to creatine ratio, it would 
seem appropriate to reiterate the comments made by Lozano et al in a presentation 
at the 55th National Congress of the Spanish Association of Hospital Pharmacists 
in 2010, where we proposed the likely influence of antipsychotic treatment on nitric 
oxide, glutamine, and glutamate levels in the brain, as a result of the reaction of nitric 
oxide with glutamine to yield glutamate and nitrogen gas. A summary of this research 
is provided as follows.
Nitric oxide is believed to have a role in the pathophysiology of schizophrenia, 
depression, and anxiety disorders. In this longitudinal cohort study, we measured 
plasma urea levels to determine the influence of antidepressant and antipsychotic 
treatment on nitric oxide synthase activity and tissue nitric oxide concentrations in the 
brain. We recruited two groups, ie, 25 patients treated with the antipsychotic risperi-
done for at least 6 weeks (AP group) and 25 patients treated with the antidepressant 
escitalopram for at least 6 weeks (AD group). Student’s t-test was used for the statisti-
cal analysis. The mean plasma urea level in the AD group was 37.7 ± 10.5 mg/dL and 
in the AP group was 2.6 ± 9.2 mg/dL. The difference between the average value for 
plasma urea in group AP compared to that obtained for group AD was 11.1 mg/dL 
(P , 0.001).
Preclinical studies have demonstrated that inhibition of nitric oxide synthase 
produces anxiolytic-like and antidepressant-like behavioral effects, and that nitric 
oxide may modulate levels of various neurotransmitters in the central nervous system, 
eg, serotonin, dopamine, gamma aminobutyric acid, and glutamate. Our results suggest 
that nitric oxide produced by the action of nitric oxide synthase on L-arginine may react 
with nitrogen in the carbamoyl group on glutamine and, via enzymes with nitric oxide 
reductase activity, generate nitrogen gas and glutamic acid, thus changing the amount 
of urea formed by the action of arginase on arginine and, therefore, its concentration in 
blood. Thus, treatment with antidepressants or antipsychotics could alter the metabolic 
pathway of arginine to yield urea or nitric oxide/nitrogen gas, increasing (if AP) or 
decreasing (if AD) urea or nitric oxide/nitrogen gas and, secondarily, excitatory glu-
tamic acid and/or inhibitory gamma aminobutyric acid levels via different pathways 
in the central nervous system.
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